Cargando…

Relationship between Maternal Serum Thyroid-Stimulating Hormone and in vitro Fertilisation-Conceived Pregnancy Outcomes

BACKGROUND: Thyroid dysfunction impairs female fertility and pregnancy outcome. Optimal preconception and gestational TSH level is still debatable in IVF-conceived pregnancies. AIMS: To explore the relationships of IVF success and pregnancy outcomes with maternal serum levels of TSH (at both preconc...

Descripción completa

Detalles Bibliográficos
Autores principales: Coussa, Ayla, Barber, Thomas M, Khrait, Zakwan, Cheaib, Samer, Hasan, Hayder A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345284/
https://www.ncbi.nlm.nih.gov/pubmed/35928463
http://dx.doi.org/10.4103/jhrs.jhrs_168_21
_version_ 1784761385247309824
author Coussa, Ayla
Barber, Thomas M
Khrait, Zakwan
Cheaib, Samer
Hasan, Hayder A
author_facet Coussa, Ayla
Barber, Thomas M
Khrait, Zakwan
Cheaib, Samer
Hasan, Hayder A
author_sort Coussa, Ayla
collection PubMed
description BACKGROUND: Thyroid dysfunction impairs female fertility and pregnancy outcome. Optimal preconception and gestational TSH level is still debatable in IVF-conceived pregnancies. AIMS: To explore the relationships of IVF success and pregnancy outcomes with maternal serum levels of TSH (at both preconception and 12-week IVF-conceived pregnancy). Also, to confirm or refute the recommended TSH level ≤2.5μIU/mL. STUDY SETTING AND DESIGN: Retrospective cohort. MATERIAL AND METHODS: 158 IVF-conceived pregnant women and 117 age-matched controls non-pregnant (≤39years, BMI 18.5-38kg/m2) were recruited. Preconception and 12-week IVF-conceived pregnancy serum samples were analysed for reproductive hormones, fasting glucose, insulin and TSH levels. Data of pregnant women at 28 weeks for GDM screening (75-gram OGTT) and up until delivery were included. STATISTICAL ANALYSIS: Binary logistic regression used to predict association between preconception TSH levels and IVF success, and pregnancy outcomes. Association of delta change of hormones was determined with linear regression. Significance level P≤0.05 with 95% confidence interval (CI). RESULTS: Overall, median (IQR) age was 32(6)years, BMI 25.4(6.9)kg/m2, HbA1c 5.2(0.52)% and TSH 1.82(1.4)μIU/mL. There was no significant association between preconception TSH level and IVF success rate. During the first trimester of IVF-conceived pregnancy, delta change in TSH level was associated with that of progesterone (P=0.03). 12-week gestation TSH level did not predict adverse pregnancy outcomes (i.e. onset of GDM, delivery type and premature delivery); but a higher TSH level predicted earlier delivery in weeks. There was a higher risk of delivery by caesarean section when TSH>2.5μIU/mL. CONCLUSION: Variation of maternal TSH within normal range (0.4-4.0μIU/mL) at preconception and 12-week gestation has no predictive effect on IVF success and pregnancy outcomes in IVF-pregnancy. Our data provide no support for a recommended preconception TSH level ≤2.5μIU/mL in IVF-conceived pregnancy, but rather promote a preconception TSH level within normal range.
format Online
Article
Text
id pubmed-9345284
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93452842022-08-03 Relationship between Maternal Serum Thyroid-Stimulating Hormone and in vitro Fertilisation-Conceived Pregnancy Outcomes Coussa, Ayla Barber, Thomas M Khrait, Zakwan Cheaib, Samer Hasan, Hayder A J Hum Reprod Sci Original Article BACKGROUND: Thyroid dysfunction impairs female fertility and pregnancy outcome. Optimal preconception and gestational TSH level is still debatable in IVF-conceived pregnancies. AIMS: To explore the relationships of IVF success and pregnancy outcomes with maternal serum levels of TSH (at both preconception and 12-week IVF-conceived pregnancy). Also, to confirm or refute the recommended TSH level ≤2.5μIU/mL. STUDY SETTING AND DESIGN: Retrospective cohort. MATERIAL AND METHODS: 158 IVF-conceived pregnant women and 117 age-matched controls non-pregnant (≤39years, BMI 18.5-38kg/m2) were recruited. Preconception and 12-week IVF-conceived pregnancy serum samples were analysed for reproductive hormones, fasting glucose, insulin and TSH levels. Data of pregnant women at 28 weeks for GDM screening (75-gram OGTT) and up until delivery were included. STATISTICAL ANALYSIS: Binary logistic regression used to predict association between preconception TSH levels and IVF success, and pregnancy outcomes. Association of delta change of hormones was determined with linear regression. Significance level P≤0.05 with 95% confidence interval (CI). RESULTS: Overall, median (IQR) age was 32(6)years, BMI 25.4(6.9)kg/m2, HbA1c 5.2(0.52)% and TSH 1.82(1.4)μIU/mL. There was no significant association between preconception TSH level and IVF success rate. During the first trimester of IVF-conceived pregnancy, delta change in TSH level was associated with that of progesterone (P=0.03). 12-week gestation TSH level did not predict adverse pregnancy outcomes (i.e. onset of GDM, delivery type and premature delivery); but a higher TSH level predicted earlier delivery in weeks. There was a higher risk of delivery by caesarean section when TSH>2.5μIU/mL. CONCLUSION: Variation of maternal TSH within normal range (0.4-4.0μIU/mL) at preconception and 12-week gestation has no predictive effect on IVF success and pregnancy outcomes in IVF-pregnancy. Our data provide no support for a recommended preconception TSH level ≤2.5μIU/mL in IVF-conceived pregnancy, but rather promote a preconception TSH level within normal range. Wolters Kluwer - Medknow 2022 2022-06-01 /pmc/articles/PMC9345284/ /pubmed/35928463 http://dx.doi.org/10.4103/jhrs.jhrs_168_21 Text en Copyright: © 2022 Journal of Human Reproductive Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Coussa, Ayla
Barber, Thomas M
Khrait, Zakwan
Cheaib, Samer
Hasan, Hayder A
Relationship between Maternal Serum Thyroid-Stimulating Hormone and in vitro Fertilisation-Conceived Pregnancy Outcomes
title Relationship between Maternal Serum Thyroid-Stimulating Hormone and in vitro Fertilisation-Conceived Pregnancy Outcomes
title_full Relationship between Maternal Serum Thyroid-Stimulating Hormone and in vitro Fertilisation-Conceived Pregnancy Outcomes
title_fullStr Relationship between Maternal Serum Thyroid-Stimulating Hormone and in vitro Fertilisation-Conceived Pregnancy Outcomes
title_full_unstemmed Relationship between Maternal Serum Thyroid-Stimulating Hormone and in vitro Fertilisation-Conceived Pregnancy Outcomes
title_short Relationship between Maternal Serum Thyroid-Stimulating Hormone and in vitro Fertilisation-Conceived Pregnancy Outcomes
title_sort relationship between maternal serum thyroid-stimulating hormone and in vitro fertilisation-conceived pregnancy outcomes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345284/
https://www.ncbi.nlm.nih.gov/pubmed/35928463
http://dx.doi.org/10.4103/jhrs.jhrs_168_21
work_keys_str_mv AT coussaayla relationshipbetweenmaternalserumthyroidstimulatinghormoneandinvitrofertilisationconceivedpregnancyoutcomes
AT barberthomasm relationshipbetweenmaternalserumthyroidstimulatinghormoneandinvitrofertilisationconceivedpregnancyoutcomes
AT khraitzakwan relationshipbetweenmaternalserumthyroidstimulatinghormoneandinvitrofertilisationconceivedpregnancyoutcomes
AT cheaibsamer relationshipbetweenmaternalserumthyroidstimulatinghormoneandinvitrofertilisationconceivedpregnancyoutcomes
AT hasanhaydera relationshipbetweenmaternalserumthyroidstimulatinghormoneandinvitrofertilisationconceivedpregnancyoutcomes